On April 24, 2020, President Donald Trump signed the Paycheck Protection Program and Health Care Enhancement Act (H.R. 266) into law. Among numerous appropriations, the measure includes $1.8 billion for the National Institutes of Health (NIH), allocated accordingly:
- $306 million for the National Cancer Institute,
- $500 million for the National Institute of Biomedical Imaging and Bioengineering, and
- $1 billion to the NIH Office of the Director.
The two institutes and director’s office were instructed to use the funds to develop, validate, improve and implement serological testing and associated technologies, point-of-care and other rapid testing, and for partnerships with governmental and non-governmental entities, to pursue activities related to the COVID-19 pandemic.